Spausdinti

Klinikinės ir molekulinės gastroenterologijos laboratorijos mokslinės publikacijos

Straipsniai  ISI Web of Science duomenų  bazės žurnaluose su aukštu svorio koeficientu (IF >9.0).

  1. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H; International IBD Genetics Consortium (IIBDGC), Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012 Nov 1;491(7422):119-24. (IF- 36,1)
  2. Ellinghaus D, Zhang H, Zeissig S, Lipinski S, Till A, Jiang T, Stade B, Bromberg Y, Ellinghaus E, Keller A, Rivas MA, Skieceviciene J, Doncheva NT, Liu X, Liu Q, Jiang F, Forster M, Mayr G, Albrecht M, Hasler R, Boehm BO, Goodall J, Berzuini CR, Lee J, Andersen V, Vogel U, Kupcinskas L, Kayser M, Krawczak M, Nikolaus S, Weersma RK, Ponsioen CY, Sans M, Wijmenga C, Strachan DP, McArdle WL, Vermeire S, Rutgeerts P, Sanderson JD, Mathew CG, Vatn MH, Wang J, Nothen MM, Duerr RH, Buning C, Brand S, Glas J, Winkelmann J, Illig T, Latiano A, Annese V, Halfvarson J, Damato M, Daly MJ, Nothnagel M, Karlsen TH, Subramani S, Rosenstiel P, Schreiber S, Parkes M, Franke A. Association Between Variants of PRDM1 and NDP52 and Crohns Disease, Based on Exome Sequencing and Functional Studies. Gastroenterology. 2013 Aug;145(2):339-47. (IF- 12,0)
  3. Burisch J, Pedersen N, Cukovic-Cavka S, Brinar M, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Andersen V, Krabbe S, Dahlerup JF, Salupere R, Nielsen KR, Olsen J, Manninen P, Collin P, Tsianos EV, Katsanos KH, Ladefoged K, Lakatos L, Björnsson E, Ragnarsson G, Bailey Y, Odes S, Schwartz D, Martinato M, Lupinacci G, Milla M, De Padova A, D'Incà R, Beltrami M, Kupcinskas L, Kiudelis G, Turcan S, Tighineanu O, Mihu I, Magro F, Barros LF, Goldis A, Lazar D, Belousova E, Nikulina I, Hernandez V, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Sebastian S, Lakatos PL, Langholz E, Munkholm P; for the EpiCom-group. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut. 2013 Apr 20. [Epub ahead of print] (IF-9,0).
  4. Travis SP, Danese S, Kupcinskas L, Alexeeva O, D'Haens G, Gibson PR, Moro L, Jones R, Ballard ED, Masure J, Rossini M, Sandborn WJ. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.  Gut. 2013 Feb 22. [Epub ahead of print]. (IF-9,0).
  5. Lepage P, Häsler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A, Ott S, Kupcinskas L, Doré J, Raedler A, Schreiber S. Twin Study Indicates Loss of Interaction Between Microbiota and Mucosa of Patients With Ulcerative Colitis.  Gastroenterology.2011 Jul;141(1):227-36, (IF - 12.0)
  6. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C, Ellinghaus D, Fehrmann RS, Floyd JA, Florin T, Franchimont D, Franke L, Georges M, Glas J, Glazer NL, Guthery SL, Haritunians T, Hayward NK, Hugot JP, Jobin G, Laukens D, Lawrance I, Lémann M, Levine A, Libioulle C, Louis E, McGovern DP, Milla M, Montgomery GW, Morley KI, Mowat C, Ng A, Newman W, Ophoff RA, Papi L, Palmieri O, Peyrin-Biroulet L, Panés J, Phillips A, Prescott NJ, Proctor DD, Roberts R, Russell R, Rutgeerts P, Sanderson J, Sans M, Schumm P, Seibold F, Sharma Y, Simms LA, Seielstad M, Steinhart AH, Targan SR, van den Berg LH, Vatn M, Verspaget H, Walters T, Wijmenga C, Wilson DC, Westra HJ, Xavier RJ, Zhao ZZ, Ponsioen CY, Andersen V, Torkvist L, Gazouli M, Anagnou NP, Karlsen TH, Kupcinskas L, Sventoraityte J, Mansfield JC, Kugathasan S, Silverberg MS, Halfvarson J, Rotter JI, Mathew CG, Griffiths AM, Gearry R, Ahmad T, Brant SR, Chamaillard M, Satsangi J, Cho JH, Schreiber S, Daly MJ, Barrett JC, Parkes M, Annese V, Hakonarson H, Radford-Smith G, Duerr RH, Vermeire S, Weersma RK, Rioux JD. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet. 2011 Mar;43(3):246-52. (IF- 36,1)
  7. Franke A, Balschun T, Sina C, Ellinghaus D, Häsler R, Mayr G, Albrecht M, Wittig M, Buchert E, Nikolaus S, Gieger C, Wichmann HE, Sventoraityte J, Kupcinskas L, Onnie CM, Gazouli M, Anagnou NP, Strachan D, McArdle WL, Mathew CG, Rutgeerts P, Vermeire S, Vatn MH; IBSEN study group, Krawczak M, Rosenstiel P, Karlsen TH, Schreiber S.Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet. 2010 Apr;42(4):292-4. (IF- 36,1)
  8. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D, Sina C, Onnie CM, Weersma RK, Stokkers PC, Wijmenga C, Gazouli M, Strachan D, McArdle WL, Vermeire S, Rutgeerts P, Rosenstiel P, Krawczak M, Vatn MH; IBSEN study group, Mathew CG, Schreiber S. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008 Nov;40(11):1319-23
  9. Kondrackiene J., Beuers U., Kupcinskas L. "Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology, 2005  Sep;129(3):894-901. (r  (IF - 13.0) .
  10. Stange EF, Travis SPL, Vermeire S, Beglinger C, Kupcinskas L, Geboes K, Barakauskiene A, Villanacci V, Von Herbay A, Warren BF, Gasche C, Tilg H, Schreiber S, Schölmerich J, Reinisch W. for the European Crohn's and Colitis Organisation (ECCO). European evidence-based consensus on the diagnosis and management of Crohn‘s disease: Definitions and diagnosis. Gut, 2006; 55 Suppl 1: i1-i15. (IF-9.0)

Kiti straipsniai  ISI Web of Science duomenų  bazės žurnaluose  su  svorio koeficientu  (IF):

  1. Skieceviciene J, Kiudelis G, Ellinghaus E, Balschun T, Jonaitis LV, Zvirbliene A, Denapiene G, Leja M, Pranculiene G, Kalibatas V, Saadati H, Ellinghaus D, Andersen V, Valantinas J, Irnius A, Derovs A, Tamelis A, Schreiber S, Kupcinskas L, Franke A. Replication Study of Ulcerative Colitis Risk Loci in a Lithuanian-Latvian Case-Control Sample. Inflamm Bowel Dis. 2013 Oct;19(11):2349-2355.
  2. Kupcinskas J, Wex T, Bornschein J, Selgrad M, Leja M, Juozaityte E, Kiudelis G, Jonaitis L, Malfertheiner P. Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. BMC Med Genet. 2011 Aug 24;12:112. (IF-2,4).
  3. Link A, Kupcinskas J, Wex T, Malfertheiner P. Macro-role of microRNA in gastric cancer. Dig Dis. 2012;30(3):255-67. (IF-2,7).
  4. Sonata Trumbeckaite, Irma Kuliaviene, Olegas Deduchovas, Marius Kincius, Rasa Baniene, Simona Virketyte, Dovidas Bukauskas, Eugene Jansen, Limas Kupčinskas, Vilmante Borutaite, Antanas Gulbinas.Experimental acute pancreatitis induces mitochondrial dysfunction in rat pancreas, kidney and lungs but not in liver  Pancreatology, 2013 May-Jun;13(3):216-24. (IF-2,0)
  5. Kuliaviene I, Gulbinas A, Cremers J, Pundzius J, Kupcinskas L, Dambrauskas Z, Jansen E. Fatty acids of erythrocyte membrane in acute pancreatitis patients. World J Gastroenterol. 2013 Sep 14;19(34):5678-84. (IF-2,4)
  6. Leja M, Funka K, Janciauskas D, Putnins V, Ruskule A, Kikuste I, Kojalo U, Tolmanis I, Misins J, Purmalis K, Pimanov S, Makarenko J, Kupcinskas L, Vikmanis U. Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy. Eur J Gastroenterol Hepatol. 2013 Jun;25(6):694-699 (IF-1,7)
  7. Kiudelis G, Jonaitis L, Adamonis K, Žvirblienė A, Tamelis A, Kregždytė R, Kučinskienė R, Šventoraitytė J, Kupčinskas L. Incidence of inflammatory bowel disease in Kaunas region, Lithuania. Medicina (Kaunas). 2012;48(8):431-5.
  8. Kupcinskas L, Rasmussen L, Jonaitis L, Kiudelis G, Jørgensen M, Urbonaviciene N, Tamosiunas V, Kupcinskas J, Miciuleviciene J, Kadusevicius E, Berg D, Andersen LP. Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania. APMIS. 2013 May;121(5):431-6. (IF-2,0).
  9. Mickevičius A, Endzinas Ž, Kiudelis M, Jonaitis L, Kupčinskas L, Pundzius J, Maleckas A. Influence of wrap length on the effectiveness of Nissen and Toupet fundoplications: 5-year results of prospective, randomized study. Surg Endosc. 2013 Mar;27(3):986-91. (IF-3,8)
  10. Agréus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen M, Perez Perez G, Rugge M, Ronkainen J, Salaspuro M, Sipponen P, Sugano K, Sung J. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol. 2012 Feb;47(2):136-47. (IF-1,7)
  11. Performance of routine Helicobacter pylori tests in patients with atrophic gastritis. Sudraba A, Daugule I, Rudzite D, Funka K, Tolmanis I, Engstrand L, Janciauskas D, Jonaitis L, Kiudelis G, Kupcinskas L, Ivanauskas A, Leja M.  J Gastrointestin Liver Dis. 2011 Dec;20(4):349-54.
  12. Jonaitis L, Kriukas D, Kiudelis G, Kupčinskas L.Risk factors for erosive esophagitis and Barrett's esophagus in a high Helicobacter pylori prevalence area. Medicina (Kaunas). 2011;47(8):434-9 (IF-0,4)
  13. Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kuidelis G, Chiu HM, Lin JT. Value of gastrin-17 in detecting antral atrophy. Adv Med Sci. 2011;56(2):145-50. (IF-1,0)
  14. Andersen V, Ernst A, Sventoraityte J, Kupcinskas L, Jacobsen BA, Krarup HB, Vogel U, Jonaitis L, Denapiene G, Kiudelis G, Balschun T, Franke A. Assessment of heterogeneity between European Populations: a Baltic and Danish replication case-control study of SNPs from a recent European ulcerative colitis genome wide association study. BMC Med Genet. 2011 Oct 13;12:139. doi: 10.1186/1471-2350-12-139.
  15. Kucinskas L, Juzenas S, Sventoraityte J, Cedaviciute R, Vitkauskiene A, Kalibatas V, Kondrackiene J, Kupcinskas L. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population. Ann Hematol. 2012 Apr;91(4):491-5.
  16. Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG, Kupcinskas L, Lesniakowski K, Grinevich VB, Malecka-Panas E, Ardizzone S, D'Arienzo A, Valpiani D, Koch M, Denapiene G, Vago G, Fociani P, Zerbi P, Ceracchi M, Camerini R, Gasbarrini G. Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Aliment Pharmacol Ther. 2011 Nov;34(9):1088-97
  17. Kiudelis, M., Mickevicius, A., Maleckas, A., Endzinas, Z., Kiudelis, G., Jonaitis, L., & Kupčinskas, L. Laparoscopic myotomy or pneumatic dilatation for achalasia treatment?. Central European Journal of Medicine, 2011. 6(5), 640-644.
  18. Kupcinskas L, Wex T, Kupcinskas J, Leja M, Ivanauskas A, Jonaitis LV, Janciauskas D, Kiudelis G, Funka K, Sudraba A, Chiu HM, Lin JT, Malfertheiner P. Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. Eur J Gastroenterol Hepatol. 2010 ;22(10):1189-95. (IF-1.66)
  19. Kupcinskas L, Malfertheiner P. Helicobacter pylori and non-malignant diseases. Helicobacter. 2005;10 Suppl 1:26-33. (IF-2.0)
  20. Kupcinskas L, Lafolie P, Lignell A, Kiudelis G, Jonaitis L, Adamonis K, Andersen LP, Wadström T.  Phytomedicine, 2008 Jun;15(6-7):391-9 (IF-2.330)
  21. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, Ochsenkühn T, Orchard T, Rogler G, Louis E, Kupcinskas L, Mantzaris G, Travis S, Stange E; European Crohn's and Colitis Organisation (ECCO). The second European evidence-based Consensus on  the diagnosis and management of Crohn's disease:  Definitions and dzagnosis. J Crohn's Colitis, 2010, 4: 7–27; (IF-2.6).
  22. EF Stange, SPL Travis, K Geboes, S Vermeire, W Reinisch, A Barakauskiene, R Feakins, JF Fléjou, H Herfarth, D Hommes, L Kupcinskas, P Lakatos, G Mantzaris, S Schreiber, M Stolte, V Villanacci, BF Warren. European Evidence-based nonsensus. the diagnosis and management of Ulcerative colitis: definitions and diagnosis. J Crohn‘s Colitis.  2008, 2, 1–23. (IF -2.6)
  23. Häsler R, Begun A, Freitag-Wolf S, Kerick M, Mah N, Zvirbliene A, Spehlmann ME, von Wurmb-Schwark N, Kupcinskas L, Rosenstiel P, Schreiber S. Genetic control of global gene expression levels in the intestinal mucosa - a human twin study.  Physiol Genomics2009, 10;38(1):73-9 (IF-3.4).
  24. Ivanauskas A, Hoffmann J, Jonaitis LV, Markelis R, Juozaityte E, Kupcinskas L, Lofton-Day C, Röcken C, Malfertheiner P. Distinct TPEF/HPP1 gene methylation patterns in gastric cancer indicate a field effect in gastric carcinogenesis. Dig Liver Dis. 2008; 40(12):920-6. (IF-2.0).
  25. Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kiudelis G, Chiu HM, Lin JT. The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard Histopathology. Dig Dis Sci. 2009 Nov;54(11):2377-84.
  26. Kupcinskas L, Jonaitis L, Kiudelis G. A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease Eur J Gastroenterol Hepatol. 2004 Apr;16(4):369-74. (IF-1.8)
  27. Jonaitis LV, Kiudelis G, Kupcinskas L. Characteristics of patients with erosive and nonerosive GERD in high-Helicobacter-pyloriprevalence region. Dis Esophagus. 2004;17(3):223-7 (IF-0.8)
  28. Dailidiene D, Bertoli MT, Miciuleviciene J, Mukhopadhyay AK, Dailide G, Pascasio MA, Kupcinskas L, Berg DE. Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother. 2002 Dec;46(12):3940-6. (IF-4.5)
  29. Boyanova L, Mentis A, Gubina M, Rozynek E, Gosciniak G, Kalenic S, Goral V, Kupcinskas L, Kantarceken B, A, Archimandritis A, Dzierzanowska D, Vcev A, Ivanova K, Marina M, Mitov I, Aydin Petrov P, Ozden A, Popova M. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 2002 Jul;8(7):388-96. (IF-2.0)
  30. Sventoraityte J, Zvirbliene A, Franke A, Kwiatkowski R, Kiudelis G, Kupcinskas L, Schreiber S.  NOD2, IL23R and ATG16L1 polymorphismsin Lithuanian patients with inflammatory bowel disease. World J Gastroenterol, 2010 16(3): 358-363 (IF -2,1).
  31. Gross V, Bar-Meir S, Lavy A, Mickisch O, Tulassay Z, Pronai L, Kupcinskas L, Kiudelis G. Pokrotnieks J, Kovac A,  Faszczyk M,. Razbadauskas A Margus B, Stolte M,  Müller R, Greinwald R.  and the International Budesonide Foam Study Group. Budesonide foam  vs.budesonide enema in active ulcerative proctitis and proctosigmoidaitis. Aliment Pharmacol Ther. 2006;  23, 303–312. (IF-3.4)
  32. R. Eliakim, Z. Tulassay, L. Kupcinskas, K. Adamonis, J. Pokrotnieks, S. Bar-Meir, A. Lavy, R. Mueller, R. Greinwald, I. Chermes, V. Gross, on behalf of the International Salofalk® Foam Study Group Randomized, controlled clinical study comparing the efficacy and safety of a low-volume versus a high-volume mesalamine foam in active distal ulcerative colitis.  Aliment Pharmacol Ther, 2007, 26, 1237–1249. (IF-3.4)
  33. Kucinskas L, Jeroch J, Vitkauskiene A, Sakalauskas R, Petrenkiene V, Kucinskas V, Naginiene R, Schmidt H, Kupcinskas L. High frequency of the c.3207C>A (p.H1069Q) mutation in ATP7B gene of Lithuanian patients with hepatic presentation of Wilson’s disease. World J Gastroenterol 2008 October 14; 14(38): 5876-9. (IF-2.1).
  34. C. van Rensburg, A.N. Barkun, I. Racz, R. Fedorak, P. C. Borman, C. Berlinger, J. Balanzo, J. Deviere, L. Kupcinskas, R. Luehmann, H. Doerfler, S. Schafer-Preuss. Intravenous pantoprazole versus ranitidine for the prevention of peptic ulcer rebleeding: a multicenter, multinational, randomized trial  Aliment Pharmacol Ther. 2009; 29, 497–07 ( IF-3.4);
  35. Kondrackiene J, Kupcinskas L. Intrahepatic cholestasis of pregnancy - current achievements and unsolved problems World J Gastroenterol 2008; 14(38): 5781-8 (IF-2,1)
  36. Pribuisiene R, Uloza V, Kupcinskas L, Jonaitis L. Perceptual and Acoustic Characteristics of Voice Changes in Reflux Laryngitis Patients. J Voice. 2006, 20 (1):  128-136. (IF-0.8)
  37. Kupcinskas L,  Petrauskas D., Petrenkiene V, Katkus K. Prevalence of chronic virus hepatitis B and risk factors for hepatitis B virus among Lithuanian Army soldiers. Military medicine, 2007, Volume 172, Number 6, June 2007, 625-627. (IF-1,0)
  38. Kupcinskas L. Chronic Hepatitis in West and East. Dig Dis. 2007;25 (3) 25:274–276. (IF-1.5).
  39. Janulaityte-Günther D, Kupcinskas L, Pavilonis A, Valuckas K, Wadström T, Andersen LP. Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer. FEMS Immunol Med Microbiol. 2007 Jul;50(2):220-5. (IF-1.8)
  40. Andersen LP, Holck S, Kupcinskas L, Kiudelis G, Jonaitis L, Janciauskas D, Permin H, Wadström T. Gastric inflammatory markers and interleukins in patients with functional dyspepsia treated with astaxanthin. FEMS Immunol Med Microbiol. 2007 Jul;50(2):244-8. (IF-1.8)
  41. Andersen LP, Holck S, Janulaityte-Günther D, Kupcinskas L, Kiudelis G, Jonaitis L, Janciauskas D, Holck P, Bennedsen M, Permin H, Norn S, Wadström T. Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without Helicobacter pylori infection. FEMS Immunol Med Microbiol. 2005 May 1;44(2):233-8. (IF-1.8)
  42. Janulaityte-Gunther D, Kucinskiene R, Kupcinskas L, Pavilonis A, Labanauskas L, Cizauskas A, Schmidt U, Wadström T, Andersen LP. The humoral immuneresponse to Helicobacter pylori infection in children with gastrointestinal symptoms. FEMS Immunol Med Microbiol. 2005 May 1;44(2):205-12. (IF-1.8)
  43. Jonaitis L Pribuisiene R, Kupcinskas L, Uloza V. Larhyngoscopic examination is superior endoscopy in patients with laryngeal form of gastroesophageal reflux disease. Scand J.Gastroenterol. 2006, 41: 131-137. (IF-1.8) 
  44. Kaspari S, Kupcinskas L., Heinze H., Berghöfer P. Pantoprazole 20 mg on-demand is effective in the long-term management  of patients with mild GERD. Eur J Gastroenterol Hepatol. 2005 Sep;17(9):935-41. (IF-1.8)
  45. Mickevicius A, Endzinas Z, Kiudelis M, Jonaitis L, Kupcinskas L, Maleckas A, Pundzius J. Influence of wrap lenth on efecctivesnes of Nisen and Touplet fundoaplications. A prospective randomised study. Surgical endoscopy.  2008;22(10):2269-76. (IF-3.2)
  46. Daugule I, Sudraba A, Chiu HM, Funka K, Ivanauskas A, Janciauskas D, Jonaitis L, Kiudelis G, Tolmanis I, Vanags A, Lin JT, Kupcinskas L, Leja M. Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage.. Eur J Gastroenterol Hepatol. 2011 Apr;23(4):302-7. (IF-1,7)
  47. Gross V, Bunganic I, Belousova EA, Mikhailova TL, Kupcinskas L, Kiudelis G, Tulassay Z, Gabalec L, Dorofeyev AE, Derova J, Dilger K, Greinwald R, Mueller R; International BUC-57 Study Group. 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: a double-blind, double-dummy, randomised trial. J Crohns Colitis. 2011 Apr;5(2):129-38. (IF-2,7)
  48. Sumskiene J, Janciauskas D, Pilkauskaite G, Kristalnyj V, Kupcinskas L.  An unusual case of bleeding from stomach due to a giant diospyrobezoar.  Medicina (Kaunas). 2009;45(6):476-9. (IF-0,506)
  49. Silkauskaitė V, Pranculis A, Mitraitė D, Jonaitis L, Petrenkienė V, Kupčinskas L. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding. Medicina (Kaunas). 2009;45(1):8-13. (IF-0,506).
  50. Jonaitis L, Kupčinskas J, Kiudelis G, Kupčinskas L. De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study. Medicina (Kaunas). 2010;46(7):454-9. (IF-0,5)